Literature DB >> 16616432

Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats.

Z Kovács1, K A Kékesi, N Szilágyi, I Abrahám, D Székács, N Király, E Papp, I Császár, E Szego, K Barabás, H Péterfy, A Erdei, T Bártfai, G Juhász.   

Abstract

In normal rats the proinflammatory cytokines like interleukin-1beta, interleukin-6, which are induced by bacterial lipopolysaccharides, are able to control thalamo-cortical excitability by exerting strong effects on physiological synchronization such as sleep and on pathological synchronization like that in epileptic discharges. To investigate whether proinflammatory cytokines or lipopolysaccharides could modulate absence seizures resulting from a very different generator mechanism than the already investigated bicuculline-, kindling- and kainate-induced seizures, we used a genetically epileptic Wistar Albino Glaxo/Rijswijk rat strain, which is spontaneously generating high voltage spike-wave discharges. Wistar Albino Glaxo/Rijswijk rats responded with an increase of the number of spike-wave discharges to lipopolysaccharide injection (from 10 microg/kg to 350 microg/kg). Repetitive administration of 350 microg/kg lipopolysaccharides daily for 5 days increased the number of spike-wave discharges on the first, second and third days but the number of spike-wave discharges returned to the control value on day 5, at the 5th injection of lipopolysaccharides, showing a tolerance to lipopolysaccharides. The lipopolysaccharide-induced increase in spike-wave discharges was not directly correlated with the elevation of the core body temperature, as it is in febrile seizures, although lipopolysaccharide induced prostaglandin and is clearly pyrogenic at the doses used. Indomethacin, the prostaglandin synthesis inhibitor, efficiently blocked lipopolysaccharide-induced enhancement of spike-wave discharge genesis suggesting that the spike-wave discharge facilitating effect of lipopolysaccharides involves induction of cyclooxygenase 2 and subsequent synthesis and actions of prostaglandin E2. Low dose (40 mg/kg, i.p.) of competitive N-methyl-d-aspartate receptor antagonist 2-amino-5-phosphonopentanoic acid, and low dose of lipopolysaccharide (20 microg/kg) showed a synergistic interaction to increase the number of spike-wave discharges, whereas at supramaximal doses of lipopolysaccharide and the N-methyl-D-aspartate antagonist no synergy was present. The data reveal a functional connection between absence epileptic activity and lipopolysaccharide induction of prostaglandin synthesis and prostaglandin action and suggest some common cellular targets in epilepsy and lipopolysaccharide-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616432     DOI: 10.1016/j.neuroscience.2006.02.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  The neural and vascular effects of killed Su-Streptococcus pyogenes (OK-432) in preterm fetal sheep.

Authors:  L Bennet; R V Cowie; P R Stone; R Barrett; A S Naylor; A B Blood; A J Gunn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-19       Impact factor: 3.619

Review 2.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

3.  Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy.

Authors:  Alberto E Musto; Mark Samii
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

4.  Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.

Authors:  Antonio Leo; Rita Citraro; Nicola Amodio; Caterina De Sarro; Maria Eugenia Gallo Cantafio; Andrew Constanti; Giovambattista De Sarro; Emilio Russo
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

5.  Intra-hippocampal injection of lipopolysaccharide inhibits kindled seizures and retards kindling rate in adult rats.

Authors:  Amin Ahmadi; Mohammad Sayyah; Baharak Khoshkholgh-Sima; Samira Choopani; Jafar Kazemi; Mehdi Sadegh; Farshad Moradpour; Hossein Nahrevanian
Journal:  Exp Brain Res       Date:  2013-02-01       Impact factor: 1.972

Review 6.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

Review 7.  New vistas on astroglia in convulsive and non-convulsive epilepsy highlight novel astrocytic targets for treatment.

Authors:  Vincenzo Crunelli; Giorgio Carmignoto
Journal:  J Physiol       Date:  2012-12-10       Impact factor: 5.182

8.  IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy.

Authors:  Antonio Leo; Valentina Nesci; Martina Tallarico; Nicola Amodio; Eugenia M Gallo Cantafio; Giovambattista De Sarro; Andrew Constanti; Emilio Russo; Rita Citraro
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 9.  Novel astrocyte targets: new avenues for the therapeutic treatment of epilepsy.

Authors:  Vincenzo Crunelli; Giorgio Carmignoto; Christian Steinhäuser
Journal:  Neuroscientist       Date:  2014-03-07       Impact factor: 7.519

Review 10.  From Physiology to Pathology of Cortico-Thalamo-Cortical Oscillations: Astroglia as a Target for Further Research.

Authors:  Davide Gobbo; Anja Scheller; Frank Kirchhoff
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.